Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
952,757
-
Share change
-
-49,866
-
Total reported value
-
$55,873,605
-
Put/Call ratio
-
390%
-
Price per share
-
$58.67
-
Number of holders
-
40
-
Value change
-
-$3,054,320
-
Number of buys
-
15
-
Number of sells
-
21
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2019
As of 30 Jun 2019 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 952,757 shares of stock of the company.
Largest 10 holders included CLS Investments, LLC, GOLDMAN SACHS GROUP INC, Western Wealth Management, LLC, BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), MORGAN STANLEY, OPPENHEIMER & CO INC, and LPL Financial LLC.
This table shows 40 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.